SCHEMBL6949304

SCHEMBL6949304

N#Cc1c(N2CCc3ccccc3CC2)nc(=O)[nH]c1OCC(F)(F)F

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.37
KDM4E B2RXH2 6/20 0.37
L3MBTL1 Q9Y468 2/20 0.37
MAPK1 P28482 2/20 0.37
HPGD P15428 5/20 0.37
MEN1 O00255 4/20 0.37
KMT2A Q03164 4/20 0.37
HTT P42858 3/20 0.37
HSD17B10 Q99714 2/20 0.37
TP53 P04637 1/20 0.37
MAPT P10636 1/20 0.37
LMNA P02545 2/20 0.35
GAA P10253 2/20 0.35
TDP1 Q9NUW8 1/20 0.35
KHK P50053 2/20 0.35
TSHR P16473 1/20 0.34
GRM2 Q14416 1/20 0.34
PDE9A O76083 1/20 0.33
POLB P06746 1/20 0.33
RAB9A P51151 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6957307 0.77 LMNA (0.44) ALDH1A1KDM4EL3MBTL1MAPK1HPGD
SCHEMBL6950069 0.76 KDM4E (0.42) ALDH1A1KDM4EL3MBTL1MAPK1HPGD
SCHEMBL6956303 0.76 KDM4E (0.41) ALDH1A1KDM4EL3MBTL1MAPK1HPGD
SCHEMBL6950658 0.76 LMNA (0.43) ALDH1A1KDM4EL3MBTL1MAPK1HPGD
SCHEMBL6948239 0.74 PIK3CD (0.39) ALDH1A1KDM4EL3MBTL1MAPK1HPGD
SCHEMBL6957239 0.74 PIK3CD (0.40) ALDH1A1KDM4EL3MBTL1MAPK1HPGD
SCHEMBL6951385 0.74 GRM2 (0.40) ALDH1A1KDM4EL3MBTL1MAPK1HPGD
SCHEMBL6949294 0.74 KDM4E (0.43) ALDH1A1KDM4EL3MBTL1MAPK1HPGD
SCHEMBL6947632 0.74 PIK3CD (0.39) ALDH1A1KDM4EL3MBTL1MAPK1HPGD
SCHEMBL6955400 0.73 PIK3CD (0.38) ALDH1A1KDM4EL3MBTL1MAPK1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1074549-B1 Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors HOFFMANN LA ROCHE (CH) 2003-11-19 EP disclosed
US-6218385-B1 FOR THERAPY OR PROPHYLAXIS OF ACUTE AND/OR CHRONIC NEUROLOGICAL DISORDERS SUCH AS EPILEPSY, STROKE, CHRONIC AND ACUTE PAIN, PSYCHOSIS, SCHIZOPHRENIA, ALZHEIMER'S DISEASE, COGNITIVE DISORDERS AND MEMORY DEFICITS HOFFMANN-LA ROCHE INC. 2001-04-17 US disclosed
EP-1074549-A2 Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors F. HOFFMANN-LA ROCHE AG (CH) 2001-02-07 EP disclosed